Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain, sickle cell disease, beta thalassemia, and type 1 diabetes, with approved products in each area. Suzetrigine ...

This program targets the root causes of back pain rather than merely alleviating the symptoms, offering you a chance to reclaim your life without prescription medications or invasive surgeries.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. About one in five Americans suffer from high impact chronic pain – enough pain to interfere ...

– Rolling submission for suzetrigine moderate-to-severe acute pain NDA granted by FDA; first module submitted and on track to complete filing this quarter – – Successful completion of end-of-phase 2 ...

Please provide your email address to receive an email when new articles are posted on . STOMP program interventions reduced pain severity both immediately and after 3 months. Adjustments to the ...

Registration Now Open for 20 th Anniversary Event Taking Place in Las Vegas September 8-11, with the Pre-Conference Workshop on September 7 The theme of the event, "Dimensions of Care: Weaving the ...